April 26 (Reuters) - Biodel Inc., a specialty pharmaceutical company, said its initial public offering of 5 million shares is expected to be priced between $14 to $16 per share.
April 26 (Reuters) - Biodel Inc., a specialty pharmaceutical company, said its initial public offering of 5 million shares is expected to be priced between $14 to $16 per share.